Ratings by Loop Capital (Jason Wittes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/10/2023 | Globus Medical | GMED | Downgrade | Hold (Buy) |
62.97 (87.10) |
38.32% | Details | |
| 2/1/2023 | Stryker | SYK | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Stereotaxis | STXS | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Brainsway | BWAY | New Coverage | Buy (N/A) |
7.85 (12.34) |
57.2% | Details | |
| 1/5/2022 | Stereotaxis | STXS | New Coverage | Buy (N/A) |
6.44 (2.05) |
-68.17% | Details | |
| 12/22/2021 | Accuray | ARAY | New Coverage | Buy (N/A) |
4.72 (0.49) |
-89.62% | Details | |
| 12/7/2021 | Stryker | SYK | New Coverage | Buy (N/A) |
246.87 (364.56) |
47.67% | Details | |
| 12/7/2021 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
121.22 (124.14) |
2.41% | Details | |
| 10/29/2021 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
11.76 (12.23) |
4% | Details | |
| 10/29/2021 | Globus Medical | GMED | New Coverage | Buy (N/A) |
77.08 (87.10) |
13% | Details | |
| 2/8/0008 | NovoCure Ltd. | NVCR | New Coverage | Buy (N/A) |
71.24 (13.04) |
-81.7% | Details |
